List of works - Thomas Carter

A Model Agreement for Genetic Research in Socially Identifiable Populations ⬇️

scientific article published on September 1, 1998

A fatal case of West Nile virus infection in a bone marrow transplant recipient

scientific article published on 6 October 2003

A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia

scientific article

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

scientific article

Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia

scientific article

Aspartate-specific peptidases in Salmonella typhimurium: mutants deficient in peptidase E ⬇️

scientific article published on August 1, 1984

BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

scientific article

Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

scientific article

Communal discourse as a supplement to informed consent for genetic research

scientific article published in November 1997

Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation

scientific article published on 01 February 2000

Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score

scientific article published on 30 December 2013

Expression and prognostic impact of lncRNAs in acute myeloid leukemia

scientific article

FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

scientific article

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study

scientific article

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

scientific article

Genetic screening of targeted subpopulations: the role of communal discourse in evaluating sociocultural implications

scientific article

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

scientific article

In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline

scientific article published on 10 June 2013

Marrow and stem cell transplantation in Oklahoma: fifteen years of experience and results.

scientific article

Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

scientific article

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia

scientific article

Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia

scientific article published on 22 May 2017

Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8.

scientific article

RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures

scientific article

Resistance to transformation by insertionally activated c-erbB is a dominant phenotype in fibroblasts

scientific article published on September 1995

Retroviral Mutagenesis of Cellular Oncogenes: A Review with Insights into the Mechanisms of Insertional Activation ⬇️

scientific article published on January 1, 1991

Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease

scientific article published in November 2000

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study

scientific article

The influence of health insurance on outcomes of related-donor hematopoietic stem cell transplantation for AML and CML

article

The role of community review in evaluating the risks of human genetic variation research.

scientific article

Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor

scientific article

miR-3151 Interplays With its Host Gene BAALC and Independently Impacts on Outcome of Older Patients With Cytogenetically Normal Acute Myeloid Leukemia by Direct Deregulation of TP53

article

miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia

scientific article

List of works by Thomas Carter

A Model Agreement for Genetic Research in Socially Identifiable Populations ⬇️

A fatal case of West Nile virus infection in a bone marrow transplant recipient

A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia

Aspartate-specific peptidases in Salmonella typhimurium: mutants deficient in peptidase E ⬇️

BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

Communal discourse as a supplement to informed consent for genetic research

Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation

Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score

Expression and prognostic impact of lncRNAs in acute myeloid leukemia

FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

Genetic screening of targeted subpopulations: the role of communal discourse in evaluating sociocultural implications

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline

Marrow and stem cell transplantation in Oklahoma: fifteen years of experience and results.

Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia

Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia

Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8.

RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures

Resistance to transformation by insertionally activated c-erbB is a dominant phenotype in fibroblasts

Retroviral Mutagenesis of Cellular Oncogenes: A Review with Insights into the Mechanisms of Insertional Activation ⬇️

Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study

The influence of health insurance on outcomes of related-donor hematopoietic stem cell transplantation for AML and CML

The role of community review in evaluating the risks of human genetic variation research.

Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor

miR-3151 Interplays With its Host Gene BAALC and Independently Impacts on Outcome of Older Patients With Cytogenetically Normal Acute Myeloid Leukemia by Direct Deregulation of TP53

miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia